XML 31 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
Warrants (Tables)
3 Months Ended
Mar. 31, 2018
Warrants [Abstract]  
Outstanding Warrants to Purchase Common Stock
The following table summarizes outstanding warrants to purchase the Company’s common stock:
 
Number of warrants
 
 
 
 
 
March 31, 2018
 
December 31, 2017
 
Exercise
Price
 
Expiration
Dates
Liability-classified Warrants
 
 
 
 
 
 
 
Issued with June 2012 Convertible Notes
375,194

 
375,194

 
$
7.50

 
Jun 2018
Issued in Series E Preferred Stock offering
523,045

 
523,045

 
$
22.50

 
Dec 2018
Issued with September 2016 Convertible Notes
6,029,174

 
6,029,174

 
$
4.50

 
Sep 2021
Total liability-classified warrants
6,927,413

 
6,927,413

 
 
 
 
 
 
 
 
 
 
 
 
Equity-classified Warrants
 
 
 
 
 
 
 
   Issued in 2017 Series A Preferred Stock Offering
3,437,334

 
3,437,334

 
$
2.54

 
Mar 2022
Issued in December 2017 Common Stock Offering - common warrants
14,046,950

 
14,046,950

 
$
0.77

 
Dec 2022
Issued in December 2017 Common Stock Offering - underwriter warrants
436,364

 
436,364

 
$
0.9625

 
Dec 2022
Issued in December 2017 Common Stock Offering - pre-funded warrants

 
2,416,104

 
$
0.01

 
No exp
Total equity-classified warrants
17,920,648

 
20,336,752

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total outstanding warrants
24,848,061

 
27,264,165

 
 

 
 
Schedule of Warrants Outstanding Roll Forward
The table below is a summary of the Company’s warrant activity during the three months ended March 31, 2018:
 
Number of warrants
 
Weighted-
average
exercise
price
 
Liability-classified
Equity-classified
Total
 
Outstanding at December 31, 2017
6,927,413

20,336,752

27,264,165

 
$
2.26

Granted



 

Exercised

(2,416,104
)
(2,416,104
)
 
0.01

Expired



 

Outstanding at March 31, 2018
6,927,413

17,920,648

24,848,061

 
$
2.48

Summary of Other Assumptions Used by Entity
The following table summarizes the calculated aggregate fair values, along with the inputs and assumptions utilized in each calculation:
 
 
 
 
($ in thousands except per share data)
March 31, 2018
 
December 31, 2017
Calculated aggregate value
$
838

 
$
1,073

Weighted average exercise price per share
$
6.02

 
$
6.02

Closing price per share of common stock
$
0.59

 
$
0.64

Volatility
93.0
%
 
92.2
%
Weighted average remaining expected life
3 years, 1 month

 
3 years, 4 months

Risk-free interest rate
2.34
%
 
2.00
%
Dividend yield